Leukemia Cell Bank
Coordinator: 
Claude Rondeau
(514) 252-3400 ext. 3327 or 4678
crondeau.hmr@ssss.gouv.qc.ca
Director: Josée Hébert
Phone: (514) 252-3404
jhebert.hmr@ssss.gouv.qc.ca
Created in 2001, the Quebec Leukemia Cell Bank (QLCB) is a provincial program financed by the Réseau de la Recherche sur le Cancer of the Fonds de Recherche en Santé du Québec (FRSQ). It brings together hematologists, research investigators and clinical scientists from four Quebec universities (University of Laval, McGill University, University of Sherbrooke and University of Montreal)and all of Quebec’s research centres. Its laboratories are located at the CRHMR.
Objectives
The QLCB aims to provide hematology, oncology and immunology research investigators with an infrastructure and services that enable them to:
- Understand the mechanisms that are involved in blood cancers;
- Improve the diagnosis, prognosis and treatment of blood cancers;
- Provide specialists and students with quality training.
Equipment and Services
- Hematologic Cancer Specimen Analysis and Storage
The QLCB is a bank of well-identified human hematological neoplasis cells. The constitutional DNA is preserved for each specimen and database software that compile all laboratory analyses conducted on the specimens as well as their corresponding clinical data.
- Cytogenetics Program
The Molecular Cytogenetic Facility (HMR-IRIC) provides research investigators with cytogenetic analysis services (standard and molecular cytogenetics) on human and mouse specimens. It is the only facility that offers spectral karyotyping services (SKY) in Quebec. It can classify with great precision complex abnormalities of the chromosome found in experimental mouse models affected by cancer. This facility is vital to adequately characterizing cytogenetic abnormalities in human forms of cancer that often have a very complex karyotype. This facility also provides training to specialists working in this field.
For more information, please visit the QLCB’s web site.